Amy E. Veroff
Amy E. Veroff publishes mostly in Psychiatry and Mental health, Cognitive Neuroscience and Physiology, on topics such as Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Functional Brain Connectivity Studies.
- World rank
- #4,074,918 of 7,710,434 ranked researchers
- Rank in United States
- #1,107,327 of 1,627,098
- Works
- 37
- Citations
- 794
- Citations per work
- 21.5
What does Amy E. Veroff research?
Amy E. Veroff's work is mostly in Medicine (52%), Neuroscience (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1952.0%
- Medicine1952.0%
- Everything else1231.5%
- Life Sciences616.5%
- Neuroscience616.5%
- 1Psychiatry and Mental health30% of their works
- 2Cognitive Neuroscience16% of their works
- 3Physiology9% of their works
- 4Pharmacology5% of their works
- 5Cardiology and Cardiovascular Medicine4% of their works
- 6Geriatrics and Gerontology4% of their works
Research topics
- Dementia and Cognitive Impairment Research
- Alzheimer's disease research and treatments
- Functional Brain Connectivity Studies
- Cholinesterase and Neurodegenerative Diseases
- Pharmaceutical Practices and Patient Outcomes
- Attention Deficit Hyperactivity Disorder
- Cancer-related cognitive impairment studies
- Meta-analysis and systematic reviews
Which keywords describe Amy E. Veroff's research?
The keywords of their largest research topics: Alzheimer's Disease, Dementia, Mild Cognitive Impairment, Amyloid Hypothesis, Meta-Analysis, Tau Pathology, Acetylcholinesterase and Cholinesterase Inhibitors.
- Quality Assessment
- PRISMA Statement
- Cognitive Function
- Attention-Deficit/Hyperactivity Disorder
- Resting-State fMRI
- Cholinesterase Inhibitors
- Tau Pathology
- Amyloid Hypothesis
- Dementia
- Alzheimer's Disease
- Mild Cognitive Impairment
- Meta-Analysis
- Acetylcholinesterase
- Functional Connectivity
- ADHD
- Chemotherapy
- Inappropriate Medication Use
- Polypharmacy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Alzheimer's Disease212 topics
- Dementia171 topic
- Mild Cognitive Impairment171 topic
- Amyloid Hypothesis61 topic
- Meta-Analysis62 topics
- Tau Pathology61 topic
- Acetylcholinesterase41 topic
- Cholinesterase Inhibitors41 topic
- Functional Connectivity41 topic
- Resting-State fMRI41 topic
- ADHD31 topic
- Attention-Deficit/Hyperactivity Disorder31 topic
- Chemotherapy31 topic
- Cognitive Function31 topic
- Inappropriate Medication Use31 topic
- PRISMA Statement31 topic
- Polypharmacy31 topic
- Quality Assessment31 topic
Where does Amy E. Veroff work?
Amy E. Veroff's main affiliation in the publication record is Los Angeles Clinical Trials, United States.
How many publications and citations does Amy E. Veroff have?
OpenAlex counts 37 works and 794 citations for Amy E. Veroff, an h-index of 15, ranking #4,074,918 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Amy E. Veroff. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.